凯发一触即发

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression.

Cell Rep. 2018; 
Lin CH, Wong SH, Kurzer JH, Schneidawind C, Wei MC, Duque-Afonso J, Jeong J, Feng X, Cleary ML.
Products/Services Used Details Operation
Monoclonal Antibody Services The blots were reacted with primary antibodies specific to histone H3 (ab1791, Abcam), histone H3K9me3 (ab8898, Abcam), GAPDH (G9545, Sigma-Aldrich), a-tubulin (A01410-40, GenScript), S-Tag (A190-135A, Bethyl Laboratories), SETDB2 (M17, Abnova), or E2A (3C6, monoclonal antibody specific for E2A) (Jacobs et al. Get A Quote

摘要

Acute lymphoblastic leukemia (ALL) is associated with significant morbidity and mortality, necessitating further improvements in diagnosis and therapy. Targeted therapies directed against chromatin regulators are emerging as promising approaches in preclinical studies and early clinical trials. Here, we demonstrate an oncogenic role for the protein lysine methyltransferase SETDB2 in leukemia pathogenesis. It is overexpressed in pre-BCR+ ALL and required for their maintenance in vitro and in vivo. SETDB2 expression is maintained as a direct target gene of the chimeric transcription factor E2A-PBX1 in a subset of ALL and suppresses expression of the cell-cycle inhibitor CDKN2C through histone H3K9 tri-methylati... More

关键词

CDKN2C; E2A-PBX1; SETDB2; acute leukemia; cell-cycle inhibition; preB-ALL